Home›Compare›Eden vs MadeMed

Eden vs MadeMed: Which Is Better?

Head-to-head comparison of Eden and MadeMed based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Eden scores higher overall in our independent evaluation (63.8/100 vs 57.3/100), leading on trust & safety, value, experience, reputation. MadeMed comes out ahead on product range. MadeMed has the lower entry price (from $30/mo vs $124/mo), so the better value depends on which treatment you need.

64
Eden
Fair

DTC telehealth platform specializing in compounded GLP-1 weight-loss medications with flat-rate dose-independent pricing and the world's first compounded GLP-1 gummy.

Visit Eden
57

MadeMed is a Houston-registered telehealth brand selling compounded injectable and oral GLP-1s, sermorelin, NAD+ and tadalafil through the Xpedicare provider network.

Visit MadeMed

Score Breakdown

DimensionEdenMadeMed
Overall Score63.8/100 ✓57.3/100
Trust & Safety30%65/100 ✓55/100
Value25%70/100 ✓66/100
Experience20%60/100 ✓45/100
Product Range15%55/10072/100 ✓
Reputation10%65/100 ✓45/100

At a Glance

Founded2020—
HeadquartersDenver, COHouston, TX
Publicly tradedNoNo
Treatment categories73
Treatments listed57
Starting price$124/mo$30/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryEdenMadeMed
Weight Loss / GLP-1$198
Compounded Semaglutide (Injectable)
$99–$199
Compounded Semaglutide (injectable)
Sexual Health$168
ED Treatment (Tadalafil + Vardenafil)
$30–$90
Tadalafil
Longevity & Peptides$215
NAD+ Anti-Aging Injections
$129–$229
Sermorelin (injectable or oral)

Eden

+Flat-rate dose-independent GLP-1 pricing — cost doesn't increase with dose escalation
+World's first compounded GLP-1 Rx gummy (needle-free alternative)
+Fast approval and overnight shipping; streamlined signup-to-medication process
−Advertised monthly rates assume three- or six-month plans on most products while the site also advertises no long-term contracts
−The Eden-branded vial images the FDA objected to were still on the site on 2026-09-19, three months after a fifteen-working-day response deadline; the FDA-licensed wording has been corrected
−FDA warning letter (June 2026, ref 728279) — cited for picturing Eden-branded vials implying Eden compounds the drugs, and for claiming FDA-licensed 503(a) outsourcing facilities
Read the full Eden review →

MadeMed

+Offers both injectable and oral/sublingual versions of semaglutide, tirzepatide and sermorelin, plus NAD+ as injection or nasal spray
+Operating entity, provider network (Xpedicare) and a partner pharmacy (Red Rock) are named in the terms and About page
+Advertised GLP-1 entry pricing from $99/mo is at the low end of the market
−Product pages showed no pricing or product detail during our research, in a direct fetch or a real browser
−Advertised prices and state coverage (about 40 states) come from brand-issued press releases and can't be verified on-site
−No Trustpilot or other independent patient reviews; public coverage is mostly paid newswire content
Read the full MadeMed review →

Eden vs MadeMed — FAQ

Is Eden better than MadeMed?

▾

Eden scores higher overall in our independent evaluation (63.8/100 vs 57.3/100), leading on trust & safety, value, experience, reputation. MadeMed comes out ahead on product range. MadeMed has the lower entry price (from $30/mo vs $124/mo), so the better value depends on which treatment you need.

Is Eden or MadeMed cheaper?

▾

MadeMed has the lower starting price (from $30/mo vs $124/mo for Eden). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Eden and MadeMed both offer?

▾

Both platforms treat Weight Loss / GLP-1, Sexual Health, Longevity & Peptides. Eden covers 7 treatment categories total and MadeMed covers 3.

Still deciding?